accountHuman Genome Sciences Inc shares rose nearly 12 percent on Tuesday on rumors that Glaxo may buy the long-struggling biotech.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Human Genome shares jump on Glaxo takeover chatter
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
